Left ventricular hypertrophy: virtuous intentions, malign consequences (Q35099126)

6 August 2017

1 reference

title

Left ventricular hypertrophy: virtuous intentions, malign consequences (English)

1 reference

left ventricular hypertrophy

6 August 2017

1 reference

2

Umesh C Sharma

1 reference

6 August 2017

Saraswati Pokharel

1

1 reference

PubMed ID

12676167

6 August 2017

Yigal M Pinto

series ordinal

3

1 reference

6 August 2017

1 June 2003

1 reference

International Journal of Biochemistry & Cell Biology

6 August 2017

1 reference

6 August 2017

35

1 reference

6 August 2017

6

1 reference

6 August 2017

802-806

1 reference

Pressure overload induces cardiac hypertrophy in angiotensin II type 1A receptor knockout mice.

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900344-8

7 January 2021

Signaling pathways for cardiac hypertrophy and failure

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900344-8

7 January 2021

Activation of NADPH oxidase during progression of cardiac hypertrophy to failure

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900344-8

7 January 2021

Left ventricular hypertrophy: pathogenesis, detection, and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900344-8

7 January 2021

Mechanisms and models in heart failure: A combinatorial approach

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900344-8

7 January 2021

Lessons from rat models of hypertension: from Goldblatt to genetic engineering

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900344-8

7 January 2021

Reduction in Left Ventricular Messenger RNA for Transforming Growth Factor β 1 Attenuates Left Ventricular Fibrosis and Improves Survival Without Lowering Blood Pressure in the Hypertensive TGR(mRen2)27 Rat

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900344-8

7 January 2021

Prevalence of left ventricular hypertrophy in a general population; The Tromsø Study

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900344-8

7 January 2021

Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900344-8

7 January 2021

The influence of antihypertensive drug treatment on the prevention and regression of left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900344-8

7 January 2021

Normalization of diastolic dysfunction in aortic stenosis late after valve replacement

1 reference

https://api.crossref.org/works/10.1016%2FS1357-2725%2802%2900344-8

7 January 2021

10.1016/S1357-2725(02)00344-8

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12676167